A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids

Cancer Research

Volumn 60, Issue 9, 2000, Pages 2512-2519

  Chakraborty, Ashok K ^a   Sodi, Stefano ^a   Rachkovsky, Michael ^a   Kolesnikova, Natalia ^a   Platt, James T ^a   Bolognia, Jean L ^a   Pawelek, John M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; FLOW CYTOMETRY; IMPLANTATION; LUNG METASTASIS; MACROPHAGE ACTIVATION; MALIGNANT TRANSFORMATION; MELANOGENESIS; MELANOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINOPTERIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL MOVEMENT; CHEMOTAXIS; FLOW CYTOMETRY; GENTAMICINS; HYPOXANTHINE; IMMUNOBLOTTING; LUNG NEOPLASMS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; MONOPHENOL MONOOXYGENASE; NEOPLASM TRANSPLANTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA; THYMIDINE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034194240     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Van Noorden, C. J. F., Meade-Tollin, L. C., and Bosman, F. T. Metastasis. Am. Sci., 86: 130-141, 1998.
2. Stracke, M. L., and Liotta, L. A. Molecular mechanisms of tumor cell metastasis. In: J. Mendelsohn, P. M. Howley, M. A. Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp. 233-247. Philadelphia: W. B. Saunders Co., 1995.
3. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379: 88-91, 1996.
4. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-28, 1976.
5. Fidler, I. J., and Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science (Washington DC), 197: 893-895, 1977.
6. Collard, J. G., Roos, E., La Riviere, G., and Habets, G. G. M. Genetic analysis of invasion and metastasis. Cancer Surv., 7: 691-710, 1988.
7. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mutations of mitotic checkpoint genes in human cancers. Nature (Lond.), 392: 300-304, 1998.
8. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instabilities in human cancers. Nature (Lond.)., 396: 643-649, 1998.
9. Morita, R., Fujimoto, A., Hatta, N., Takehara, K., and Takata, M. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression. J. Investig. Derm., 111: 919-924, 1998.
10. Aichel, O. Uber Zellverschmelzung mit qualitative abnormer chromosomenverteilung. In: W. Roux (ed.), Vorträge und Aufsätze über Entvickelungsmechanik Der Organismen, pp. 1-115. Leipzig, Germany: Wilhelm Engelmann, 1911.
11. Mekler, L. B. Hybridization of transformed cells with lymphocytes as one of the probable courses of the progression leading to the development of metastatic malignant cells (in Russian). Vestn. Akad. Med. Nauk SSSR, 26: 80-89, 1971.
12. Kerbel, R. S., Lagarde, A. E., Dennis, J. W., and Donaghue, T. P. Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol. Cell. Biol., 3: 523-538, 1983.
13. Larizza, L., and Schirrmacher, V. Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants. Cancer Metastasis Rev., 3: 193-222, 1984.
14. DeBaetselier, P., Roos, E., Brys, L., Remels, L., and Feldman, M. Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma by in vivo fusion with normal host cells. Int. J. Cancer, 34: 731-738, 1984.
15. Lagarde, A. E., and Kerbel, R. S. Somatic cell hybridization in vivo and in vitro in relation to the metastatic phenotype. Biochim. Biophys. Acta, 823: 81-110, 1985.
16. Rachkovsky, M., Sodi, S., Chakraborty, A., Avissar, Y., Bolognia, J., Madison McNiff, J., Platt, J., Bermudes, D., and Pawelek, J. Melanoma × macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis, 16: 299-312, 1998.
17. Margulis, L., and Sagan, D. Microcosmos: Four Billion Years of Evolution from Our Microbial Ancestors, pp. 281. New York: Simon and Schuster, 1991.
18. Martin, W., and Muller, M. The hydrogen hypothesis for the first eukaryote. Nature (Lond.), 392: 37-41, 1998.
19. Weinstein, I. B., Carothers, A. M., Santella, R. M., and Perera, F. P., Molecular mechanisms of mutagenesis and multistage carcinogenesis. In: J. Mendelsohn, P. M. Howley, M. A. Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp. 59-85. Philadelphia: W. B. Saunders Co., 1995.
20. Gauwerky, C. E., and Croce, C. M. Molecular genetics and cytogenetics of hematopoietic malignancies. In: J. Mendelsohn, P. M. Howley, M. A. Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp. 18-37. Philadelphia: W. B. Saunders Co., 1995.
21. Wikonkal, N. M., and Brash, D. E. Ultraviolet radiation induced signature mutations in photocarcinogenesis J. Investig. Dermatol., 4: 6-10, 1999.
22. Munzarova, M., and Kovrik, J., Is cancer a macrophage-mediated autoaggressive disease? Lancet, i: 952-954, 1987.
23. Munzarova, M., Lauerova, L., and Capkova, J. Are advanced malignant melanoma cells hybrids between melanocytes and macrophages? Melanoma Res., 2: 127-129, 1992.
24. Pawelek, J. M. Melanoma as a macrophage/melanocyte hybrid and the symbiotic nature of eukaryotic cells. Melanoma Res., 3: 75-76, 1993.
25. Sodi, S. A., Chakraborty, A. K., Platt J. T., Kolesnikova, N., Rosemblat, S., Keh-Yen, A., Bolognia, J. L., Rachkovsky, M. L., Orlow, S. J., and Pawelek, J. M. Melanoma × macrophage fusion hybrids acquire increased melanogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism. Pigm. Cell Res., 11: 299-309, 1998.
26. Rachkovsky, M., and Pawelek, J. Acquired melanocyte stimulating hormone-inducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells. Cell Growth Differ., 10: 515-524, 1999.
27. Chakraborty, A. K., Funasaka, Y., Ichihashi, M., Sodi, S., Bhattacharya, M., and Pawelek, J. Up-regulation of mRNA for the melanocortin-1 receptor but not for melanogenic proteins in macrophage × melanoma fusion hybrids exhibiting increased melanogenic and metastatic potential. Pig. Cell Res., 45: 1011-1027, 1999.
28. Pawelek, J. M., Chakraborty, A. K., Rachkovsky, M. L., Orlow, S. J., Bolognia, J. L., and Sodi, S. A. Altered N-glycosylation in macrophage × melanoma fusion hybrids. Cell. Mol. Biol., 45: 1011-1027, 1999.
29. Littlefield, J. W. The use of drug-resistant markers to study the hybridization of mouse fibroblasts. Exp. Cell Res., 41: 190-196, 1966.
30. Crissman, H. A., and Hirons, G. T. Staining of DNA in live and fixed cells Methods Cell Biol., 41: 195-209, 1994.
31. Pawelek, J. M. In: D. W. Barnes, D. A. Sirbasku, and G. H. Sato (eds.), Methods for Serum-Free Culture of Neuronal and Lymphoid Cells, pp. 57-66. New York: Alan R. Liss, Inc., 1984.
32. Orlow, S. J., Boissy, R. E., Moran, D. J., and Pilfko-Hirst, S. Subcellular distribution of tyrosinase and tyrosinase-related protein-1: implications for melanosomal biogenesis. J. Investig. Dermatol., 100: 55-64, 1993.
33. Pawelek, J., Sansone, M., Morowitz, J., Moellmann, G., and Godawska, E. Genetic control of melanization: isolation and analysis of amelanotic variants from cultured melanotic melanoma cells. Proc. Natl. Acad. Sci. USA, 71: 1073-1077, 1974.
34. Muller, G., Ruppert, S., Schmid, E., and Schutz, G. Functional analysis of alternatively spliced tyrosinase gene transcripts. EMBO J., 7: 2723-2730, 1988.
35. Shibahara, S., Okinaga, S., Tomita, Y., Takeda, A., Yamamoto, H., Sato, M., and Takeuchi, T. A point mutation in the tyrosinase gene of BALB/c albino mouse causing the cysteine-serine substitution at position 85. Eur. J. Biochem., 189: 455-461, 1990.
36. Jackson, I. J., and Bennett, D. C. Identification of the albino mutation of mouse tyrosinase by analysis of an in vitro revertant. Proc. Natl. Acad. Sci. USA, 87: 7010-7014, 1990.
37. Mishima, Y. Cellular and subcellular differentiation of melanin phagocytosis and synthesis by lysosomal and melanosomal activity. J. Investig. Dermatol., 46: 70-75, 1966.
38. Hori, Y., Toda, K., Pathak, M. A., Clark, W. H. Jr, and Fitzpatrick, T. B. A fine-structure study of the human epidermal melanosome complex and its acid phosphatase activity. J. Ultrastruct. Res., 25: 109-120, 1968.
39. Horikoshi, T., Jimbow, K., and Sugiyama, S. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex, and malignant melanoma. J. Cutan. Pathol., 9: 329-339, 1982.
40. Crowson, A. N., Magro, C. M., and Mihm, M. C., Jr. Malignant melanoma with prominent pigment synthesis: "animal type" melanoma - a clinical and histological study of six cases with a consideration of other melanocytic neoplasms with prominent pigment synthesis. Hum. Pathol., 30: 543-550, 1999.
41. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am., 271: 58-65, 1994.
42. Savill, J., Fadok, V., Henson, P., and Haslett, C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today, 14: 131-136, 1993.
43. Fadok, V. A., and Henson, P. M. Apoptosis. Getting rid of the bodies. Curr. Biol., 8: R693-R695, 1998.
44. de la Taille, A., Chen, M-W., Burchardt, M., Chopin, D. K., and Buttyan, R. Apoptotic conversion: evidence for exchange of genetic information between prostate cancer cells mediated by apoptosis. Cancer Res., 59: 5461-5463, 1999.
45. Holmgren, L., Szeles, A., Rajnavolgyi, E., Folkman, J., Klein, G., Ernberg, I., and Falk, K. I. Horizontal transfer of DNA by the uptake of apoptotic bodies. Blood, 93: 3956-3963, 1999.
46. Spetz, A. L., Patterson, B. K., Lore, K., Andersson, J., and Holmgren, L. Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism. J. Immunol., 163: 736-742, 1999.
47. Harris, H. The analysis of malignancy by cell fusion: the position in 1988. Cancer Res., 48: 3302-3306, 1988.
48. Weinberg, A. S. Tumor suppressor genes. Science (Washington DC), 254: 1138-1146, 1991.
49. Levine, A. J. Tumor suppressor genes. In: J. Mendelsohn, P. M. Howley, M. A. Israel, and L. A. Liotta (eds.), The Molecular Basis of Cancer, pp. 86-104. Philadelphia: W. B. Saunders Co., 1995.
50. Warner, T. F. C. S. Cell hybridization. An explanation for the phenotypic diversity of certain tumours. Med. Hypotheses, 1: 51-57, 1975.
51. Clark, W. H. Jr., Mastrangelo, M. J., Ainsworth, A. M., Berg, D., Bellet, R. E., and Bernardino, E. A. Current concepts of the biology of human cutaneous malignant melanoma. Adv. Cancer Res., 24: 267-338, 1997.
52. Davidson, R. L., Ephrussi, R. L. B., and Yamamoto, K. Regulation of pigment synthesis in mammalian cells, as studied by somatic hybridization. Proc. Natl. Acad. Sci. USA, 56: 1437-1440, 1966.
53. Darlington, G. J., Bernhard, H. P., and Ruddle, F. H. Human serum albumin phenotype activation in mouse hepatoma-human leukocyte cell hybrids. Science (Washington DC), 185: 859-862, 1974.
54. Malawista, S. E., and Weiss, M. C. Expression of differentiated function in hepatoma cell hybrids: high frequency of induction of mouse albumin production in rat hepatoma-mouse lymphoblast hybrids. Proc. Natl. Acad. Sci. USA, 71: 927-931, 1974.
55. Giacomoni, D. Tumorigenicity and intracisternal A-particle expression of hybrids between murine myeloma and lymphocytes. Cancer Res., 39: 4481-4484, 1979.
56. Kohler, G., and Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (Lond.), 256: 495-497, 1975.
57. Hu, F., and Pasztor, L. M. In vivo hybridization of cultured melanoma cells and isogenic normal mouse cells. Differentiation, 4: 93-97, 1975.
58. Halaban, R., Nordlund, J., Francke, U., Moellmann, G., and Eisenstadt, J. M. Supermelanotic hybrids derived from mouse melanomas and normal mouse cells. Somatic Cell Genet., 6: 29-44, 1980.
59. Dick, W. Melanosis in men and horses. Lancet, i: 192, 1832.
60. Darier, J. Le melanome malin mesenchymateaux ou melanosarcome. Bull. Assoc. Fr. Cancer, 14: 221-249, 1925.